Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gaining Market Share for Nonparametric Statistics Michael J. Schell Moffitt Cancer Center University of South Florida.

Similar presentations


Presentation on theme: "Gaining Market Share for Nonparametric Statistics Michael J. Schell Moffitt Cancer Center University of South Florida."— Presentation transcript:

1 Gaining Market Share for Nonparametric Statistics Michael J. Schell Moffitt Cancer Center University of South Florida

2 Web of Science Source of count data for this talk Words/phrases found in title or abstract Mainly title only references before 1991 The number of articles has increased over the years, thus the need for benchmarking

3

4 But is the Market Itself Expanding?

5

6

7

8 Non-Linear Regression Methods

9

10

11

12 Article Counts and Growth Rate of Regression Sub-Fields Sub-Field1990-942005-07*GR Non-linear146924943.4 Wavelets1025611411.9 Linear436082813.8 Logistic429116,7287.8 Mixed models75028177.5 Data mining112979542 Bioinformatics144194599 * Estimated 5-year rate obtained by doubling the count GR = Growth Rate

13 How Many Discoveries Have Been Lost by Ignoring Modern Statistical Methods? Rand R. Wilcox, American Psychologist, 1998 Arbitrarily small departures from normality result in low power; even when distributions are normal, heteroscedasticity can seriously lower the power of standard ANOVA and regression methods. … most quantitative articles tend to be too technical for applied researchers. If the goal is to avoid low power, the worst method is the ANOVA F test. …the Theil-Sen estimator deserves consideration as well.

14 British Medical Journal articles by Doug Altman The scandal of poor medical research, 1994 Why are errors so common? Put simply, much poor research arise because researchers feel compelled for career reasons to carry out research that they are ill equipped to perform, and nobody stops them. Statistics and ethics in medical research. The misuse of statistics is unethical, 1980

15 Marketing of Pharmaceuticals 1)Must have the produced the drug and shown its efficacy 2)Need to produce the drug in mass quantities 3)Marketing

16 Marketing of Statistical Ideas 1)Must have derived the statistic and demonstrated its efficacy 2)Need to have available software 3)Need to disseminate the idea

17 Key Principle In an environment where ideas are not marketed, first on the market wins

18 First-on-the-market winners T-test, 1905 ANOVA Kolmogorov-Smirnov test, 1937 Duncan’s test, 1950 Kaplan-Meier curves, 1958 Cox regression, 1972

19 Hodges and Lehmann, 1961 4 th Berkeley Symposium Chernoff and Savage (1958) proved that the ARE of the normal scores test is at least 1 “The above results suggest that on the basis of power, at least for large samples, both the Wilcoxon and normal scores tests are preferable to the t-test for general use.”

20 First Simulation on Robustness of t-test CA Boneau, 1960 320 citations Conclusion: t-test is fine, exponential distribution simulation was done wrong Highest citation count on any subsequent simulation study (39 thru 2000) = 96

21 Textbook Placement Basic Practice of Statistics, 4 th Ed. 2006 David S. Moore (728 pages) Non-parametric tests don’t make the book; they appear in the virtual appendix. Statistics: A Biomedical Introduction, 1977 Hollander and Wolfe T-test in Chapter 5; Wilcoxon in Chapter 13 Biostatistics, 2 nd Ed. van Belle, Fisher, et al., 2004 T-test in Chapter 5; Wilcoxon in Chapter 8

22 One-Way Layout for Books of Psalms Book NMnSDSkKurt RangeMd 14115.09.31.94.65-5012 23115.08.01.10.95-3612 31721.116.72.35.47-7218 41718.913.21.20.55-4815 54415.926.15.634.52-43,176 9 150

23 Results ANOVAp =.7015 ANOVA on logged data p =.0586 Kruskal-Wallisp =.0458 Normal scoresp =.0378 AD sum for data: 14 = 2.2 + 1.0 + 2.0 + 0.9 + 7.9 AD sum for log data: 1.9 = 0.3 + 0.3 + 0.5 + 0.2 + 0.6

24 Deciding Between ANOVA and KW on Principle If one is convinced that the metric of the values is what one wants, then ANOVA is fine ANOVA – political kin is the monarchy KW – political kin is democracy Power assessed as P(X < Y)

25 Cancer Research It has been my experience as a statistician in cancer research, that we are: 1)rarely sure of the metric for the data, 2)typically interested in answering the democratic question Thus, nonparametric analysis has predominated in my applied articles

26 Ethical Considerations Applied statistical work is very important in decision-making Educators have an ethical responsibility to properly train their “tool user” students in best practices “Tool user” statisticians have an ethical responsibility to seek best practice information


Download ppt "Gaining Market Share for Nonparametric Statistics Michael J. Schell Moffitt Cancer Center University of South Florida."

Similar presentations


Ads by Google